214 related articles for article (PubMed ID: 26404131)
21. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
[TBL] [Abstract][Full Text] [Related]
22. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.
Ferreira LB; Tavares C; Pestana A; Pereira CL; Eloy C; Pinto MT; Castro P; Batista R; Rios E; Sobrinho-Simões M; Gimba ER; Soares P
Oncotarget; 2016 Aug; 7(32):52003-52016. PubMed ID: 27409830
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
[TBL] [Abstract][Full Text] [Related]
25. PARP1-siRNA suppresses human prostate cancer cell growth and progression.
Lai Y; Kong Z; Zeng T; Xu S; Duan X; Li S; Cai C; Zhao Z; Wu W
Oncol Rep; 2018 Apr; 39(4):1901-1909. PubMed ID: 29393407
[TBL] [Abstract][Full Text] [Related]
26. OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.
Ferreira LB; Lima RT; Bastos ACSDF; Silva AM; Tavares C; Pestana A; Rios E; Eloy C; Sobrinho-Simões M; Gimba ERP; Soares P
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274371
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.
Puhr M; Hoefer J; Schäfer G; Erb HH; Oh SJ; Klocker H; Heidegger I; Neuwirt H; Culig Z
Am J Pathol; 2012 Dec; 181(6):2188-201. PubMed ID: 23041061
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance.
Mirzaei A; Mohammadi S; Ghaffari SH; Yaghmaie M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):615-623. PubMed ID: 29580029
[TBL] [Abstract][Full Text] [Related]
30. Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review).
Gimba ERP; Brum MCM; Nestal De Moraes G
Int J Oncol; 2019 Feb; 54(2):420-430. PubMed ID: 30535434
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Ferreira LB; Eloy C; Pestana A; Lyra J; Moura M; Prazeres H; Tavares C; Sobrinho-Simões M; Gimba E; Soares P
Eur J Endocrinol; 2016 Apr; 174(4):551-61. PubMed ID: 26811408
[TBL] [Abstract][Full Text] [Related]
32. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
33. Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.
Hernandez JR; Kim JJ; Verdone JE; Liu X; Torga G; Pienta KJ; Mooney SM
Med Oncol; 2015 May; 32(5):159. PubMed ID: 25850653
[TBL] [Abstract][Full Text] [Related]
34. Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Jámbor K; Koroknai V; Kiss T; Szász I; Pikó P; Balázs M
Pathol Oncol Res; 2022; 28():1610608. PubMed ID: 36091936
[TBL] [Abstract][Full Text] [Related]
35. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.
Shi GH; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Xiao WJ; Ma CG
Acta Pharmacol Sin; 2010 Jul; 31(7):867-73. PubMed ID: 20581857
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.
Blasberg JD; Goparaju CM; Pass HI; Donington JS
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1587-93. PubMed ID: 19818970
[TBL] [Abstract][Full Text] [Related]
37. S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells.
Amaral CL; Freitas LB; Tamura RE; Tavares MR; Pavan IC; Bajgelman MC; Simabuco FM
BMC Cancer; 2016 Aug; 16():602. PubMed ID: 27491285
[TBL] [Abstract][Full Text] [Related]
38. EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells.
Pu YS; Huang CY; Wu HL; Wu JH; Su YF; Yu CR; Lu CY; Wu WJ; Huang SP; Huang YT; Hour TC
Kaohsiung J Med Sci; 2024 Jan; 40(1):23-34. PubMed ID: 37916740
[TBL] [Abstract][Full Text] [Related]
39. Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Ng CY; Chipitsyna G; Gong Q; Witkiewicz A; Weber GF; Denhardt DT; Yeo CJ; Arafat HA
Surgery; 2009 Aug; 146(2):232-40. PubMed ID: 19628079
[TBL] [Abstract][Full Text] [Related]
40. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.
Yu J; Lu Y; Cui D; Li E; Zhu Y; Zhao Y; Zhao F; Xia S
Oncol Rep; 2014 Feb; 31(2):910-8. PubMed ID: 24317363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
